Clinical Trials on RNA

Total 23168 results

Novartis

Completed

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations

Taiwan
National Research Centre for the Working Environment...
Rigshospitalet, Denmark; University of Copenhagen; University Hospital Bispebjerg...

Recruiting

Effect on Markers of Cardiovascular, Reproductive and Cancer Risk From Firefighting Training (BIOBRAND3)

Oxidative Stress | Heart Rate Variability | Heat Stress | Reactive Hyperemia | Micro RNA | DNA Strand Breaks

Denmark
University Hospital, Geneva
Prof Laurent Kaiser; Dr Samuel Cordey; Dr Stavroula Masouridi-Levrat; Prof Christian... and other collaborators

Completed

DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients (GeBVir)

RNA Virus Infections | DNA Virus Infections | Hematopietic Stem Cell Transplantation | Blood Virome

Switzerland
University of California, Los Angeles
National Institute on Aging (NIA)

Enrolling by invitation

Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange (GenX)

Virus Infection, RNA

United States
Avva Rus, JSC
St. Vladimir Moscow Children's Clinical Hospital; Arhangelsk Regional Children...

Unknown

A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis (F-GE-09)

Viral Gastroenteritis

Russian Federation
Duke University

Completed

GM03 - Platelet RNA Signatures of Aspirin

Aspirin | Platelet Aggregation Inhibitors | Ticagrelor | RNA

United States
Merck Sharp & Dohme LLC

Completed

Hepatitis B Challenge Dose in Adults (V232-059-10)

Hepatitis B
University of California, Davis

Completed

The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening

Hepatitis B
GlaxoSmithKline

Completed

A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

Hepatitis B

Germany
The University of Hong Kong

Completed

ID HBV Vaccination With Imiquimod in OBI

Hepatitis B

Hong Kong
Maastricht University Medical Center
CyTuVax

Completed

Hepatitis B Vaccine for Non-responders

Hepatitis B

Belgium, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

Hepatitis B

Germany
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

Hepatitis B | Hepatitis A

Belgium, Czech Republic
Merck Sharp & Dohme LLC

Completed

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

Hepatitis B
GlaxoSmithKline

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Hepatitis B

Spain, Czech Republic, Malaysia
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Hepatitis B
Georgetown University
Cangene Corporation

Completed

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Hepatitis B

United States
Western Galilee Hospital-Nahariya

Withdrawn

Prevalence of Hepatitis B Infection in the Galilee Region, Israel

Hepatitis B
GlaxoSmithKline

Completed

Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians (PRALINE)

Hepatitis B

France
University of Aarhus
Aarhus University Hospital; Monash Medical Centre

Unknown

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Hepatitis B

Denmark
Far Eastern Memorial Hospital

Unknown

Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults

Hepatitis B

Taiwan
Institut Pasteur
Institut National de la Santé Et de la Recherche Médicale, France; Gilead Sciences and other collaborators

Completed

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule (NEOVAC2BK)

Hepatitis B

Burkina Faso
Oslo University Hospital
The Research Council of Norway; University of Agder; Addis Ababa University; St... and other collaborators

Active, not recruiting

Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa

Hepatitis B

Ethiopia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant

Hepatitis B

United States
Sinovac Biotech Co., Ltd

Completed

Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)

Hepatitis B

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Hepatitis B | Hepatitis A

China
University of Oxford

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Hepatitis B

United Kingdom
GlaxoSmithKline

Completed

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

Hepatitis B | Hepatitis A

Germany, Belgium, Czechia
Peking University
Shenzhen Kangtai Biological Products Co., LTD; Guangxi Center for Disease Control... and other collaborators

Completed

A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults

Hepatitis B

China
Huashan Hospital

Completed

Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission

Hepatitis B

China
University of British Columbia
Canadian Institutes of Health Research (CIHR); Canadian Immunization Research...

Completed

Hepatitis B Booster Study in Adolescence

Hepatitis B

Canada
Corporacion Parc Tauli
Hospital Mutua de Terrassa; Consorci Sanitari de Terrassa

Completed

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

Hepatitis B

Spain
GlaxoSmithKline

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine

Hepatitis B

Australia, Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

Hepatitis B

Slovakia
GlaxoSmithKline

Completed

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

Hepatitis B | Hepatitis A

Belgium, Czechia
GlaxoSmithKline

Completed

Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults

Hepatitis B | Hepatitis A

Germany, Belgium
GlaxoSmithKline

Completed

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Hepatitis B

Germany
GlaxoSmithKline

Completed

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Hepatitis B

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype

Hepatitis B
GlaxoSmithKline

Completed

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Hepatitis B | Hepatitis A

Australia
Jiangsu Province Centers for Disease Control and...
Beijing Tiantan Biological Products Co., Ltd.

Completed

Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

Hepatitis B

China
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Hepatitis B Seroepidemiology Among Young Adults

Hepatitis B

Taiwan
Public Health Service of Amsterdam
UMC Utrecht

Unknown

Cohort of Hepatitis B Research of Amsterdam (COBRA)

Hepatitis B

Netherlands

3

Subscribe